BAL PHARMA Financial Statement Analysis
|
||
|
The Revenues of BAL PHARMA have increased by 11.51% YoY .
The Earnings Per Share (EPS) of BAL PHARMA has increased by 185.37 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
BAL PHARMA Last 5 Annual Financial Results
[BOM: 524824|NSE : BALPHARMA]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹339 Cr | ₹304 Cr | ₹281 Cr | ₹251 Cr | ₹171 Cr |
| Expenses | ₹308 Cr | ₹279 Cr | ₹257 Cr | ₹226 Cr | ₹166 Cr |
| Operating Profit (Excl OI) | ₹32 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr | ₹5.03 Cr |
| Other Income | ₹2.85 Cr | ₹0.94 Cr | ₹5.15 Cr | ₹1.14 Cr | ₹1.85 Cr |
| Interest | ₹15 Cr | ₹12 Cr | ₹11 Cr | ₹12 Cr | ₹13 Cr |
| Depreciation | ₹10 Cr | ₹9.13 Cr | ₹9.04 Cr | ₹9.52 Cr | ₹7.68 Cr |
| Profit Before Tax | ₹9.05 Cr | ₹4.75 Cr | ₹9.18 Cr | ₹4.10 Cr | ₹-14 Cr |
| Profit After Tax | ₹7.45 Cr | ₹2.62 Cr | ₹5.71 Cr | ₹4.71 Cr | ₹-13 Cr |
| Consolidated Net Profit | ₹7.39 Cr | ₹2.57 Cr | ₹5.61 Cr | ₹4.74 Cr | ₹-12 Cr |
| Earnings Per Share (Rs) | ₹4.68 | ₹1.64 | ₹3.79 | ₹3.20 | ₹-8.62 |
| PAT Margin (%) | 2.19 | 0.86 | 2.03 | 1.88 | -7.53 |
| ROE(%) | 11.19 | 4.31 | 10.34 | 8.97 | -21.65 |
| ROCE(%) | 12.13 | 9.56 | 12.33 | 9.72 | -0.44 |
| Total Debt/Equity(x) | 2.01 | 2.05 | 1.80 | 2.09 | 2.26 |
Key Financials |
||
| Market Cap | : | ₹ 208.4 Cr |
| Revenue (TTM) | : | ₹ 324.3 Cr |
| Net Profit(TTM) | : | ₹ 7.7 Cr |
| EPS (TTM) | : | ₹ 4.8 |
| P/E (TTM) | : | 27.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BAL PHARMA | 10.2% | 0.5% | 25.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | -7.1% | 48% |
| CIPLA | -3.5% | -5.2% | 18% |
| DR REDDYS LABORATORIES | -3.9% | -10.1% | 10.1% |
| ZYDUS LIFESCIENCES | -0.3% | -7.3% | 52.2% |
| DIVIS LABORATORIES | 1.5% | -2.1% | 63% |
| MANKIND PHARMA | -2.3% | -3% | 39.6% |
| TORRENT PHARMACEUTICALS | -1.8% | -10.2% | 51.3% |
| LUPIN | -2.4% | -6.4% | 73.9% |
BAL PHARMA Revenues
[BOM: 524824|NSE : BALPHARMA]
| Y-o-Y | 11.51 % |
| 5 Yr CAGR | 18.66 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹339 Cr | 11.51 | |
| Mar2023 | ₹304 Cr | 8.18 | |
| Mar2022 | ₹281 Cr | 12.25 | |
| Mar2021 | ₹251 Cr | 46.43 | |
| Mar2020 | ₹171 Cr | - | |
BAL PHARMA Operating Profit
[BOM: 524824|NSE : BALPHARMA]
| Y-o-Y | 25.59 % |
| 5 Yr CAGR | 58.48 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹32 Cr | 25.59 | |
| Mar2023 | ₹25 Cr | 5.30 | |
| Mar2022 | ₹24 Cr | -2.70 | |
| Mar2021 | ₹25 Cr | 390.23 | |
| Mar2020 | ₹5.03 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 12.65 % |
| 5 Yr CAGR | 33.54 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 9.35% | 12.65 | |
| Mar2023 | 8.3% | -2.70 | |
| Mar2022 | 8.53% | -13.31 | |
| Mar2021 | 9.84% | 234.69 | |
| Mar2020 | 2.94% | - | |
BAL PHARMA Profit After Tax
[BOM: 524824|NSE : BALPHARMA]
| Y-o-Y | 187.40 % |
| 5 Yr CAGR | Positive |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹7.39 Cr | 187.40 | |
| Mar2023 | ₹2.57 Cr | -54.17 | |
| Mar2022 | ₹5.61 Cr | 18.35 | |
| Mar2021 | ₹4.74 Cr | Positive | |
| Mar2020 | ₹-12 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 154.65 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 2.19 % | 154.65 | |
| Mar2023 | 0.86 % | -57.64 | |
| Mar2022 | 2.03 % | 7.98 | |
| Mar2021 | 1.88 % | Positive | |
| Mar2020 | -7.53 % | - | |
BAL PHARMA Earnings Per Share (EPS)
[BOM: 524824|NSE : BALPHARMA]
| Y-o-Y | 185.37 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹4.68 | 185.37 | |
| Mar2023 | ₹1.64 | -56.73 | |
| Mar2022 | ₹3.79 | 18.44 | |
| Mar2021 | ₹3.20 | Positive | |
| Mar2020 | ₹-8.62 | - | |
BAL PHARMA Return on Capital Employed (ROCE)
[BOM: 524824|NSE : BALPHARMA]
| Y-o-Y | 26.88 % |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 12.13% | 26.88 | |
| Mar2023 | 9.56% | -22.47 | |
| Mar2022 | 12.33% | 26.85 | |
| Mar2021 | 9.72% | Positive | |
| Mar2020 | -0.44% | - | |
BAL PHARMA Share Price vs Sensex
| Current Share Price | : | ₹131.1 |
| Current MarketCap | : | ₹ 208.4 Cr |
| Updated EOD on | : | Nov 19,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 10.2% |
0.5% |
25.1% |
| SENSEX | -2.4% |
-4.2% |
19.5% |
BAL PHARMA related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about BAL PHARMA Financials
How the annual revenues of BAL PHARMA have changed ?
The Revenues of BAL PHARMA have increased by 11.51% YoY .
How the Earnings per Share (EPS) of BAL PHARMA have changed?
The Earnings Per Share (EPS) of BAL PHARMA has increased by 185.37 % YoY .
Check out Intrinsic Value of Peers of BAL PHARMA
Compare Stock Analytics of Peers of BAL PHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
